Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AXTI vs GSK✓SelectedUSD · GSKAXTI vs GSK performance historyLatest closeAs of-8.08%11/16
Stock and ETF performance explorer

AXTI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+262.0%
GSK return
+214.1%
Excess return
+47.9%
Maximum drawdown
-98.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-8.1%-0.1%-8.0%-8.1%
7D-10.4%-1.3%-9.1%-10.0%
30D-25.3%+2.7%-28.0%-26.3%
3M-52.9%+2.7%-55.6%-54.0%
6M-68.9%+3.3%-72.3%-70.1%
YTD+135.2%+6.5%+128.8%+122.9%
1Y+268.4%+10.7%+257.7%+243.4%
3Y+1,794.6%+64.4%+1,730.2%+1,372.0%
5Y+327.8%+46.7%+281.1%+240.8%
10Y+639.6%+109.4%+530.3%+406.0%
All+262.0%+214.1%+47.9%+99.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling